Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Y9WZ
|
||||
Former ID |
DNC009735
|
||||
Drug Name |
SB-298
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530243] | ||
Structure |
Download2D MOL |
||||
Formula |
C20H24N4O5
|
||||
Canonical SMILES |
CCCN1C(=O)C2=C(C=C(N2)C3=CC=C(C=C3)OCC(=O)NCCO)N(C1=O)C
|
||||
InChI |
1S/C20H24N4O5/c1-3-9-24-19(27)18-16(23(2)20(24)28)11-15(22-18)13-4-6-14(7-5-13)29-12-17(26)21-8-10-25/h4-7,11,22,25H,3,8-10,12H2,1-2H3,(H,21,26)
|
||||
InChIKey |
DLDXAAWYBLTTEM-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Adenosine A2a receptor | Target Info | Inhibitor | [530243] | |
Adenosine A2b receptor | Target Info | Inhibitor | [530243] | ||
Adenosine A1 receptor | Target Info | Inhibitor | [530243] | ||
Adenosine A3 receptor | Target Info | Inhibitor | [530243] | ||
KEGG Pathway | Rap1 signaling pathway | ||||
Calcium signaling pathway | |||||
cAMP signaling pathway | |||||
Neuroactive ligand-receptor interaction | |||||
Vascular smooth muscle contraction | |||||
Parkinson's disease | |||||
Alcoholismhsa04015:Rap1 signaling pathway | |||||
Alcoholismhsa04022:cGMP-PKG signaling pathway | |||||
Sphingolipid signaling pathway | |||||
Morphine addiction | |||||
Pathway Interaction Database | HIF-2-alpha transcription factor networkcmyb_pathway:C-MYB transcription factor network | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.